Cargando…
Clinical utility of pharmacogenetic testing in children and adolescents with severe mental disorders
This is a retrospective cohort study of 20 children and adolescents to evaluate the clinical utility of a pharmacogenetic decision support tool. Twenty children and adolescents underwent pharmacogenetic testing between June 2014 and May 2017. All children and adolescents were evaluated at Puerta de...
Autor principal: | Blasco-Fontecilla, Hilario |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Vienna
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6373261/ https://www.ncbi.nlm.nih.gov/pubmed/29626260 http://dx.doi.org/10.1007/s00702-018-1882-4 |
Ejemplares similares
-
Therapeutic drug monitoring in children and adolescents with schizophrenia and other psychotic disorders using risperidone
por: Taurines, R., et al.
Publicado: (2022) -
Impact of the COVID-19 pandemic on mental health and family situation of clinically referred children and adolescents in Switzerland: results of a survey among mental health care professionals after 1 year of COVID-19
por: Werling, Anna Maria, et al.
Publicado: (2022) -
Internet-based cognitive behavioral therapy in children and adolescents with obsessive compulsive disorder: a feasibility study
por: Hollmann, Karsten, et al.
Publicado: (2021) -
Therapeutic drug monitoring of atomoxetine in children and adolescents with attention-deficit/ hyperactivity disorder: a naturalistic study
por: Ruppert, Katrin, et al.
Publicado: (2022) -
Long-term changes in serum levels of lipoproteins in children and adolescents with attention-deficit/hyperactivity disorder (ADHD)
por: Huber, Franziska, et al.
Publicado: (2023)